March 2012
Volume 53, Issue 14
ARVO Annual Meeting Abstract  |   March 2012
Genetic Analysis of a Family with a Novel Type I Fibrillinopathy
Author Affiliations & Notes
  • James A. Eadie
    Ophthalmology, William Beaumont Hospital, Royal Oak, Michigan
  • John Hart
    Ophthalmology, William Beaumont Hospital, Royal Oak, Michigan
  • Les Siegel
    Ophthalmology, William Beaumont Hospital, Royal Oak, Michigan
    Glaucoma Center of Michigan, Glaucoma Center of Michigan, Michigan
  • Footnotes
    Commercial Relationships  James A. Eadie, None; John Hart, None; Les Siegel, None
  • Footnotes
    Support  Ray Margherio Resident Research Fund
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 1564. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      James A. Eadie, John Hart, Les Siegel; Genetic Analysis of a Family with a Novel Type I Fibrillinopathy. Invest. Ophthalmol. Vis. Sci. 2012;53(14):1564.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : To describe a novel polymorphism in the Fibrillin gene (FBN1) and the associated unique Type I Fibrillinopathy phonotypic variant found in a single family.

Methods: : The proband of the study was identified in clinic after referral from an outside institution for ectopia lentis (EL). Following a careful family history that was remarkable for several other family members with zonular instability detected at the time of cataract surgery, the patient was sent for evaluation by the department of genetics at William Beaumont Hospital. A thorough workup for known causes of ectopia lentis uncovered a novel polymorphism in the FBN1 gene (c.730T>C). A pedigree was devised and, after approval by the Human Investigations Committee at William Beaumont Hospital, medical records and prospective genetic testing was obtained on eight additional family members.

Results: : The misprint mutation c.730T>C in the FBN1 gene was detected in all three family members with confirmed ectopia lentis at the time of cataract surgery. This misprint mutation resulted in a change from cysteine to arginine at amino acid position 244. In addition, this misprint was detected in 3 of 6 offspring of known carriers who had not yet undergone cataract surgery.

Conclusions: : In our genotypic and phenotypic analysis of this single family we describe a novel misprint mutation in FBN1. Because none of the family member fit the Ghent criteria for Marfan Syndrome the established diagnosis associated with this genetic presentation is Type I Fibrillinopathy. This phenotypic presentation is unique in that, although there have been reports of isolated ectopia lentis associated with FBN1 mutations, the zonular insufficiency in this family does not manifest until the time of cataract surgery. The presence of this disease entity provides a possible explanation for idiopathic zonular weakness encountered in what is expected to be routine ocular surgery.

Keywords: cataract • gene/expression • anterior segment 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.